獸醫心臟病市場－全球產業規模、佔有率、趨勢、機會、預測：按動物類型、產品、適應症、最終用途、地區和競爭格局分類，2021-2031年

全球獸醫心​​臟病市場預計將從 2025 年的 28.3 億美元成長到 2031 年的 47.1 億美元，複合年成長率為 8.86%。

這領域涵蓋專門針對伴侶動物心臟病的診斷、藥物和治療方法。推動該領域發展的關鍵因素是老年寵物心臟病發病率的上升以及人類與動物之間情感紐帶的日益加深。這促使飼主越來越傾向尋求先進的醫療服務。根據美國寵物用品協會 (APPA) 預測，到 2024 年，獸醫護理及相關產品的支出預計將達到 398 億美元，這將形成一個強大的經濟基礎，使獸醫診所能夠投資於心臟病服務和先進的診斷技術。

儘管存在一些積極因素，但由於專業心臟治療費用高昂，市場仍面臨許多障礙。購買先進的心臟超音波圖設備需要大量投資，加上複雜手術的費用，往往令預算有限的寵物飼主望而卻步。這些經濟障礙縮小了潛在患者群體，並可能阻礙高階心臟治療方案的普及，尤其是在價格敏感的地區。

市場促進因素

獸醫心臟影像影像技術的進步正在推動產業變革，使複雜心臟疾病的早期精準識別成為可能。超音波心動圖、心電圖監測和生物標記分析等領域的現代創新，使獸醫能夠在症狀惡化之前診斷出諸如二尖瓣疾病等病症。此外，人工智慧輔助技術的引入也有助於加速臨床決策和設備應用。 IDEXX Laboratories 2024 年 10 月的數據顯示，該公司全球高階設備的部署量年增 10%，印證了這一趨勢。此外，Nationwide 2024 年 4 月的報告指出，瓣膜性心臟病是犬隻第八大常見疾病，凸顯了精準檢測能力的重要性。

寵物保險覆蓋範圍的擴大也有助於寵物主人更便捷地獲得專科護理，為面臨長期心臟病治療高昂費用的飼主提供至關重要的經濟保障。隨著保險單越來越涵蓋專科轉診和慢性疾病，飼主可以更容易獲得以前難以負擔的維持生命的治療，例如心臟心律調節器和終身服藥。這種覆蓋範圍的擴大直接增加了專科診所和製藥公司的收入。根據北美寵物健康保險協會2024年4月發布的報告顯示，2023年該行業保費總額達到42.7億美元，顯示用於高級獸醫護理的資金顯著增加。

市場挑戰

全球獸醫心​​臟病市場面臨的最大障礙是專業心臟護理服務的高昂費用。購買諸如超音波心動圖等先進診斷設備和進行複雜手術需要大量投資，這迫使獸醫診所收取高額費用，加重了飼主的經濟負擔。這種經濟壓力使得專業的心臟病治療難以負擔，尤其是在寵物保險覆蓋率低的地區以及可支配收入有限的個人。

這些經濟壁壘直接限制了目標市場，阻礙了高品質心臟病解決方案的廣泛應用。當治療費用超出飼主的預算時，他們被迫推遲或放棄必要的治療，導致心臟病服務量下降。根據美國獸醫協會（AVMA）預測，到2024年，寵物就診量將下降2.3%，主要原因是價格上漲。這一降幅表明，不斷上漲的成本正在有效地將部分市場拒之門外，並阻礙了該行業的成長潛力。

市場趨勢

微創介入手術的興起正在革新市場，為高風險的開胸手術提供了更安全的導管介入替代方案。獸醫擴大採用經導管緣對緣修復等先進技術來解決二尖瓣疾病等複雜問題，從而減輕老年寵物的身體負擔並縮短康復時間。這種向更先進治療方法的轉變正顯著增加專科護理的頻率和成本。 Trupanion 於 2025 年 7 月發布的一份報告強調了市場對這些先進介入服務的強勁需求，預計犬類心臟病相關的保險索賠將激增 55%，平均索賠額將成長 34%。

同時，遠距心臟病學和遠距會診服務的蓬勃發展，正透過為全科醫生提供與心臟病專家無縫對接的途徑，幫助彌合診斷差距。這種模式依賴於整合雲端系統，能夠即時共用心電圖和超音波心動圖數據以供專家審核，但這需要對數位基礎設施進行大量投資。這種互聯醫療模式的進步正直接提陞技術提供者的收入。例如，IDEXX Laboratories 報告稱，截至 2025 年 2 月，其獸醫軟體、服務和診斷影像業務的收入成長了 13%，這凸顯了數位平台在不斷發展的遠端心臟病診斷領域中發揮的關鍵作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸醫心​​臟病市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 動物種類（伴侶動物、生產動物）
  • 依產品類型（藥品、診斷試劑）
  • 適應症（鬱血性心臟衰竭、心肌病變、心律不整等）
  • 按用途（獸醫院/診所，其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美獸醫心臟病市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲獸醫心臟病市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區獸醫心臟病市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲獸醫心臟病市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲獸醫心臟病市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球獸醫心​​臟病市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Boehringer Ingelheim International GmbH
• Jurox Pty Limited
• Ceva Animal Health, LLC
• Merck & Co., Inc.
• IDEXX
• Apex Bio Medicals
• SOUND
• GE HealthCare
• FUJIFILM Holdings America Corporation
• ESAOTE SPA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Veterinary Cardiology Market is projected to expand from USD 2.83 Billion in 2025 to USD 4.71 Billion by 2031, registering a CAGR of 8.86%. This sector encompasses specialized diagnostics, pharmaceuticals, and therapies aimed at detecting and treating heart conditions in companion animals. Growth is largely fueled by the increasing prevalence of cardiac issues in aging pets and the strengthening emotional bond between humans and animals, which encourages owners to pursue advanced medical care. According to the American Pet Products Association, spending on veterinary care and products hit $39.8 billion in 2024, creating a solid economic base that allows clinics to invest in cardiac services and modern diagnostics.

Despite these positive indicators, the market confronts a major obstacle due to the significant expenses involved in specialized cardiac care. The substantial investment needed for advanced echocardiography equipment, combined with the costs of complex surgeries, often restricts access for pet owners with limited budgets. These economic hurdles narrow the potential patient pool and threaten to stall the broader adoption of high-end cardiology solutions, particularly in areas where price sensitivity is high.

Market Driver

Advancements in technology for veterinary cardiac imaging and diagnostics are reshaping the industry by facilitating the earlier and more precise identification of complex heart disorders. Modern innovations in echocardiography, ECG monitoring, and biomarker analysis allow vets to diagnose conditions like mitral valve disease before symptoms escalate, while the addition of AI support improves clinical decision-making and equipment adoption. Data from IDEXX Laboratories in October 2024 highlighted a 10% annual increase in their global premium instrument installed base, illustrating this trend. Furthermore, a Nationwide report from April 2024 identified valvular heart disease as the eighth most common condition in dogs, underscoring the necessity for such accurate detection capabilities.

The broadening scope of pet insurance is also enhancing access to specialty care, acting as a crucial financial buffer for owners dealing with the high costs of long-term heart management. As policies increasingly cover specialist referrals and chronic conditions, owners are better positioned to afford life-extending treatments like pacemakers or lifelong medication that were once financially out of reach. This expanded coverage directly boosts revenue for specialty clinics and drug manufacturers. As reported by the North American Pet Health Insurance Association in April 2024, the industry saw $4.27 billion in total premiums in 2023, signaling a significant rise in available funds for advanced veterinary healthcare.

Market Challenge

The most significant hurdle facing the Global Veterinary Cardiology Market is the prohibitive cost associated with specialized cardiac services. Because veterinary practices must invest heavily to acquire advanced diagnostic tools like echocardiography systems and perform complex interventions, they are compelled to charge higher fees, placing a strain on pet owners. This financial pressure renders specialized cardiac procedures unattainable for many, particularly in areas with low pet insurance coverage or for individuals with limited disposable income.

These economic barriers directly constrain the addressable market and hinder the widespread uptake of premium cardiology solutions. When treatment costs surpass an owner's budget, they are often forced to delay or refuse essential care, leading to a reduction in the volume of cardiac services rendered. According to the American Veterinary Medical Association, veterinary practices saw a 2.3% drop in patient visits in 2024, largely due to rising prices. This decline demonstrates how escalating costs effectively block a portion of the market from accessing services, thereby impeding the sector's growth potential.

Market Trends

The rise of minimally invasive interventional procedures is revolutionizing the market by offering safer, catheter-based options instead of high-risk open-heart surgeries. Veterinarians are increasingly utilizing advanced methods, such as transcatheter edge-to-edge repair, to manage complex issues like mitral valve disease, resulting in less trauma and faster recovery for aging pets. This shift toward premium modalities is driving a noticeable increase in both the use and cost of specialized care. A July 2025 report by Trupanion noted that cardiology claims for dogs jumped by 55%, with the average claim value rising by 34%, highlighting the strong market movement toward these sophisticated interventional services.

Concurrently, the growth of tele-cardiology and remote consulting services is helping general practitioners bridge diagnostic gaps by providing seamless access to cardiac specialists. This model depends on integrated cloud-based systems that allow for the instant sharing of ECG and echocardiogram data for expert review, requiring significant investment in digital infrastructure. The push for this connected care model is directly boosting revenue for technology providers. For instance, IDEXX Laboratories reported in February 2025 that revenue from veterinary software, services, and diagnostic imaging grew by 13%, emphasizing the vital role digital platforms play in the expanding tele-cardiology landscape.

Key Market Players

• Boehringer Ingelheim International GmbH
• Jurox Pty Limited
• Ceva Animal Health, LLC
• Merck & Co., Inc.
• IDEXX
• Apex Bio Medicals
• SOUND
• GE HealthCare
• FUJIFILM Holdings America Corporation
• ESAOTE SPA

Report Scope

In this report, the Global Veterinary Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Cardiology Market, By Animal Type

• Companion Animals
• Production Animals

Veterinary Cardiology Market, By Product

• Pharmaceuticals
• Diagnostics

Veterinary Cardiology Market, By Indication

• Congestive Heart Failure
• Myocardial Disease
• Arrythmias
• Others

Veterinary Cardiology Market, By End Use

• Veterinary Hospitals & Clinics
• Others

Veterinary Cardiology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Cardiology Market.

Available Customizations:

Global Veterinary Cardiology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Cardiology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Companion Animals, Production Animals)
  • 5.2.2. By Product (Pharmaceuticals, Diagnostics)
  • 5.2.3. By Indication (Congestive Heart Failure, Myocardial Disease, Arrythmias, Others)
  • 5.2.4. By End Use (Veterinary Hospitals & Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Cardiology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Indication
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Cardiology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Veterinary Cardiology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Veterinary Cardiology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By End Use

7. Europe Veterinary Cardiology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Indication
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Cardiology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By End Use
  • 7.3.2. France Veterinary Cardiology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Veterinary Cardiology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Veterinary Cardiology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Veterinary Cardiology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Cardiology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Indication
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Cardiology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Veterinary Cardiology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Veterinary Cardiology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Veterinary Cardiology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Indication
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Veterinary Cardiology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Indication
      • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Cardiology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Indication
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Cardiology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE Veterinary Cardiology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa Veterinary Cardiology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By End Use

10. South America Veterinary Cardiology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Indication
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Cardiology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Indication
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia Veterinary Cardiology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Indication
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina Veterinary Cardiology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Indication
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Cardiology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Jurox Pty Limited
• 15.3. Ceva Animal Health, LLC
• 15.4. Merck & Co., Inc.
• 15.5. IDEXX
• 15.6. Apex Bio Medicals
• 15.7. SOUND
• 15.8. GE HealthCare
• 15.9. FUJIFILM Holdings America Corporation
• 15.10. ESAOTE SPA

16. Strategic Recommendations

17. About Us & Disclaimer